Literature DB >> 6092370

Human plasma gelsolin binds to fibronectin.

S E Lind, P A Janmey.   

Abstract

Human plasma gelsolin, a 93,000-dalton actin-binding protein binds to human plasma fibronectin. Qualitative data obtained from experiments employing quasi-elastic light scattering, sucrose gradient sedimentation, gel filtration chromatography, and fibronectin polymerization indicate that gelsolin and fibronectin form a complex in solution. Solid-phase binding studies show that both human plasma and rabbit macrophage gelsolin bind to immobilized fibronectin with a Kd of about 1 microM in a 1:1 complex. The ability of gelsolin to interact with actin was not affected by the presence of fibronectin. Fibronectin also increased the amount of gelsolin binding to fibrin clots. Binding of gelsolin to fibronectin may serve to localize plasma gelsolin in regions where fibronectin is deposited, such as inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092370

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques.

Authors:  T Jagadish; G Pottiez; H S Fox; P Ciborowski
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

2.  Plasma gelsolin and circulating actin correlate with hemodialysis mortality.

Authors:  Po-Shun Lee; Kartik Sampath; S Ananth Karumanchi; Hector Tamez; Ishir Bhan; Tamara Isakova; Orlando M Gutierrez; Myles Wolf; Yuchiao Chang; Thomas P Stossel; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

3.  Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

Authors:  S E Lind; D B Smith; P A Janmey; T P Stossel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

4.  Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.

Authors:  John Audley; Emily F Gliniewicz; Kol A Zarember; Hanna S Hong; Gal Wald; Douglas B Kuhns; Elizabeth Kang; Harry L Malech; Anthony F Suffredini; Robert J Noveck; Mark J Dinubile; Susan L Levinson; Thomas P Stossel; John I Gallin
Journal:  Inflammation       Date:  2020-09-04       Impact factor: 4.092

5.  Elucidating protein inter- and intramolecular interacting domains using chemical cross-linking and matrix-assisted laser desorption ionization-time of flight/time of flight mass spectrometry.

Authors:  Gwënaël Pottiez; Pawel Ciborowski
Journal:  Anal Biochem       Date:  2011-12-13       Impact factor: 3.365

6.  Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer.

Authors:  Ming-Hung Tsai; Chih-Ching Wu; Pei-Hua Peng; Ying Liang; Yung-Chin Hsiao; Kun-Yi Chien; Jeng-Ting Chen; Shin-Jie Lin; Rei-Ping Tang; Ling-Ling Hsieh; Jau-Song Yu
Journal:  J Mol Med (Berl)       Date:  2011-10-14       Impact factor: 4.599

7.  Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients.

Authors:  Po-Shun Lee; Leslie R Drager; Thomas P Stossel; Francis D Moore; Selwyn O Rogers
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

8.  Characterization of molecules binding to the 70K N-terminal region of fibronectin by IFAST purification coupled with mass spectrometry.

Authors:  S Farshid Moussavi-Harami; Douglas S Annis; Wenjiang Ma; Scott M Berry; Emma E Coughlin; Lindsay N Strotman; Lisa M Maurer; Michael S Westphall; Joshua J Coon; Deane F Mosher; David J Beebe
Journal:  J Proteome Res       Date:  2013-06-21       Impact factor: 4.466

9.  Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.

Authors:  Nicole Haverland; Gwënaël Pottiez; Jayme Wiederin; Pawel Ciborowski
Journal:  J Transl Med       Date:  2010-12-20       Impact factor: 5.531

10.  Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis.

Authors:  Teresia M Osborn; Margareta Verdrengh; Thomas P Stossel; Andrej Tarkowski; Maria Bokarewa
Journal:  Arthritis Res Ther       Date:  2008-09-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.